Newark, New Castle, USA, May 12, 2023 (GLOBE NEWSWIRE) — According to a new study conducted by Growth Plus Reports, the leptin based therapeutics market will register a revenue CAGR of 6.35% from 2023 to 2031. The study examines the important strategies, drivers and prospects, competitive circumstances, shifting market dynamics, market size, data and forecasts, and important investment regions.
Key Takeaways:
- The increasing prevalence of obesity will drive market revenue growth.
- Increasing awareness of the effectiveness of leptin-based therapy will support market revenue growth.
- North America dominates the global leptin based therapeutics market.
Request a Free Sample of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/leptin-based-therapeutics-market/8882
Leptin Based Therapeutics Market Scope
| Report Attribute | Details |
| CAGR | 6.35% |
| Base Year for Estimation | 2022 |
| Forecast Period | 2023 to 2031 |
| Historical Year | 2021 |
| Segments Covered | Product, Technology, Services ,Distribution Channel and Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Market Drivers
The rising prevalence of obesity and metabolic diseases will drive the market’s revenue growth. Furthermore, increasing awareness regarding the efficacy of leptin-based therapy for obesity and associated diseases is expected to fuel the market’s revenue growth. Apart from this, the development of new technologies that allow for more effective administration of leptin-based medicines is expected to support the market’s revenue growth.
Market Segmentation
Growth Plus Reports has analyzed the global leptin based therapeutics market from four perspectives: Application, Type, Distribution Channel, and Region.
- Based on the application, the leptin based therapeutics market is segmented into obesity, diabetes, and others.
- Based on the type, the leptin based therapeutics market is segmented into recombinant leptin, leptin receptor agonists, and leptin antagonists.
- Based on the distribution channel, the leptin based therapeutics market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.
Application Segmentation
Based on the application, the leptin based therapeutics market is divided into three categories: obesity, diabetes, and others. Because of its increased prevalence due to urbanization, a sedentary lifestyle, and other factors, the obesity segment dominates the market.
Regional Growth Dynamics
Based on the region, the leptin based therapeutics market is segmented into North America, Europe, Latin America, and the Middle East & Africa. North America dominates the leptin based therapeutics market with the largest revenue share because of the rising prevalence of obesity and metabolic diseases, the presence of several prominent players, pharmaceutical corporations, and research institutes, and substantial R&D investments.
Request for Customization – https://www.growthplusreports.com/inquiry/customization/leptin-based-therapeutics-market/8882
Competitive Landscape
The top companies in the global leptin based therapeutics market are:
- Amgen Inc.
- AstraZeneca plc
- Rhythm Pharmaceuticals Inc.
- Zealand Pharm
- Novo Nordisk A/S
- Eli Lilly and Company
- Pfizer Inc.
- Larimar Therapeutics, Inc.
- Takeda Pharmaceuticals
- Amylin Pharmaceuticals
- Hanmi Pharm Co. Ltd.
- LG Life Sciences
The leptin-based therapeutics market is moderately competitive, with several multinational companies involved. Key players emphasize R&D to increase their product portfolio.
Recent Developments:
- Amryt, announced in January 2021 that the National Institute for Health and Care Excellence (NICE) has approved Myalepta (metreleptin) for reimbursement as a replacement therapy in England and Wales.
Table of Content
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2021
- Base Year – 2022
- Forecast Years – 2023 to 2031
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2022)
- Regulatory Landscape
- Reimbursements
- MARKET DYNAMICS
- Drivers
- Restraints/Challenges
- Opportunities
- GLOBAL LEPTIN BASED THERAPEUTICS MARKET – ANALYSIS & FORECAST, BY APPLICATION
- Obesity
- Diabetes
- Others
- GLOBAL LEPTIN BASED THERAPEUTICS MARKET – ANALYSIS & FORECAST, BY TYPE
- Recombinant Leptin
- Leptin Receptor Agonists
- Leptin Antagonists
- GLOBAL LEPTIN BASED THERAPEUTICS MARKET – ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
LEPTIN BASED THERAPEUTICS MARKET TOC
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8882
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- ‘Business Profile’ of Key Players
Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction
Visit our report store at – https://www.growthplusreports.com/report-store
Browse more latest healthcare reports:
Eosinophilia Therapeutics Market by Drug Class (Corticosteroids, Immunosuppressant), Type (Blood Eosinophilia, Tissue Eosinophilia), Route of Administration (Oral, Intravenous) – Global Outlook & Forecast 2023-2031
Mortuary Bags Market by Material (PVC, Polyethylene), Size (Adult Bags, Child/Infant Bags), End User (Hospital, Morgue) – Global Outlook & Forecast 2023-2031
Asbestosis Treatment Market by Drug Class (Corticosteroids, Expectorants), Route of Administration (Oral, Inhalation) – Global Outlook & Forecast 2023-2031
Dental Consumables Market by Product (CAD/CAM Devices, Crowns & Bridges, Dental Biomaterials), End User (Hospitals, Dental Clinics) – Global Outlook & Forecast 2023-2031
Viral Vector Production Market by Type (Adenoviral Vectors, Adeno-associated Viral Vectors, Lentiviral Vectors), Disease (Cancer, Genetic Disorders, Infectious Diseases), Application (Gene Therapy, Vaccinology) – Global Outlook & Forecast 2023-2031
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020”.
CONTACT: Manan Sethi Director, Market Insights Email: sales@growthplusreports.com 256 Chapman Road STE 105-4, Newark, New Castle - 19702, USA Phone no: +1 888 550 5009 Web: https://www.growthplusreports.com/